Gastroenterology Report最新文献

筛选
英文 中文
Advances in the management of alcohol-associated liver disease. 酒精相关肝病的治疗进展。
IF 3.8 3区 医学
Gastroenterology Report Pub Date : 2024-11-05 eCollection Date: 2024-01-01 DOI: 10.1093/gastro/goae097
Ahmad Anouti, Thomas A Kerr, Mack C Mitchell, Thomas G Cotter
{"title":"Advances in the management of alcohol-associated liver disease.","authors":"Ahmad Anouti, Thomas A Kerr, Mack C Mitchell, Thomas G Cotter","doi":"10.1093/gastro/goae097","DOIUrl":"10.1093/gastro/goae097","url":null,"abstract":"<p><p>Alcohol-associated liver disease (ALD) is a significant global health challenge, encompassing a spectrum from steatotic liver disease to cirrhosis and alcohol-associated hepatitis, and contributed to 25% of global cirrhosis deaths in 2019. The identification of both modifiable (e.g. heavy drinking, metabolic syndromes) and non-modifiable risk factors (e.g. genetic predispositions) is crucial for effective disease management. Alcohol use assessment and treatment, by using both behavioral therapy and pharmacotherapeutic modalities, nutrition support, and optimization of liver disease modifiers, form the cornerstone of management. Advances in medical therapies, such as fecal microbiota transplantation and novel agents such as IL-22, are being explored for their therapeutic potential. A unifying theme in ALD care is the need for a personalized approach to management, accounting for the spectrum of the disease and individual patient characteristics, to tailor interventions effectively. Finally, it is essential to address the challenges to effective ALD treatment, including socioeconomic, logistical, and stigma-related barriers, to improve patient outcomes. This review discusses the current knowledge on ALD, including epidemiology, pathophysiology, risk factors, and management strategies, highlighting the critical role of integrated care models.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phosphorylation of RelA/p65 Ser536 inhibits the progression and metastasis of hepatocellular carcinoma by mediating cytoplasmic retention of NF-κB p65. RelA/p65 Ser536的磷酸化通过介导NF-κB p65的细胞质滞留抑制肝细胞癌的进展和转移。
IF 3.8 3区 医学
Gastroenterology Report Pub Date : 2024-11-04 eCollection Date: 2024-01-01 DOI: 10.1093/gastro/goae094
Wentao Zuo, Haoyang Ma, Jianghui Bi, Tiaolan Li, Yifeng Mo, Shiyu Yu, Jia Wang, Beiqing Li, Jinfeng Huang, Yongwen Li, Li Li
{"title":"Phosphorylation of RelA/p65 Ser536 inhibits the progression and metastasis of hepatocellular carcinoma by mediating cytoplasmic retention of NF-κB p65.","authors":"Wentao Zuo, Haoyang Ma, Jianghui Bi, Tiaolan Li, Yifeng Mo, Shiyu Yu, Jia Wang, Beiqing Li, Jinfeng Huang, Yongwen Li, Li Li","doi":"10.1093/gastro/goae094","DOIUrl":"10.1093/gastro/goae094","url":null,"abstract":"<p><strong>Background: </strong>Intrahepatic and extrahepatic metastases contribute to the high recurrence rate and mortality of hepatocellular carcinoma (HCC). Constitutive activation of nuclear factor-κB (NF-κB) is a crucial feature of HCC. NF-κB p65 (p50-p65) is the most common dimeric form. Ser536 acts as an essential phosphorylation site of RelA/p65. However, the effect of RelA/p65 Ser536 phosphorylation on progression and metastases during intermediate and advanced HCC has not been reported.</p><p><strong>Methods: </strong>Phosphorylation of RelA/p65 (p-p65 Ser536) and NF-κB p65 were detected by using immunohistochemical staining in HCC tissue samples. The biological effects of RelA/p65 Ser536 phosphorylation were evaluated by using xenograft and metastasis models. NF-κB p65 nuclear translocation was detected by using Western blotting. The binding of NF-κB p65 to the <i>BCL2</i>, <i>SNAIL</i>, and <i>MMP9</i> promoters was detected by using chromatin immunoprecipitation. The biological effects on proliferation, migration, invasion, and epithelial-mesenchymal transition were assessed by using tetrazolium-based colorimetry, colony formation, EdU incorporation, flow cytometry, cell wound healing, and transwell assay.</p><p><strong>Results: </strong>NF-κB p65 is highly expressed, while p-p65 Ser536 is not well expressed in intermediate and advanced HCC tissues. <i>In vivo</i> experiments demonstrated that a phosphorylation-mimetic mutant of RelA/p65 Ser536 (p65/S536D) prevents tumor progression and metastasis. <i>In vitro</i> experiments showed that p65/S536D inhibits proliferation, migration, and invasion. Mechanistically, RelA/p65 Ser536 phosphorylation inhibits NF-κB p65 nuclear translocation and reduces NF-κB p65 binding to the <i>BCL2</i>, <i>SNAIL</i>, and <i>MMP9</i> promoters.</p><p><strong>Conclusions: </strong>RelA/p65 Ser536 phosphorylation was detrimental to NF-κB p65 entry into the nucleus and inhibited HCC progression and metastasis by reducing <i>BCL2</i>, <i>SNAIL</i>, and <i>MMP9</i>. The phosphorylation site of RelA/p65 Ser536 has excellent potential to be a promising target for NF-κB-targeted therapy in HCC.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142577397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exclusive enteral nutrition combined with continuous succus entericus reinfusion for high-output stoma in patients with Crohn's disease: a case report. 克罗恩病患者高输出造口的全肠内营养联合持续琥珀肠液再灌注:病例报告。
IF 3.8 3区 医学
Gastroenterology Report Pub Date : 2024-10-27 eCollection Date: 2024-01-01 DOI: 10.1093/gastro/goae100
Na Diao, Wenyou Zheng, Huiping Chen, Jian Tang
{"title":"Exclusive enteral nutrition combined with continuous succus entericus reinfusion for high-output stoma in patients with Crohn's disease: a case report.","authors":"Na Diao, Wenyou Zheng, Huiping Chen, Jian Tang","doi":"10.1093/gastro/goae100","DOIUrl":"10.1093/gastro/goae100","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11513195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cooperation of Wnt/β-catenin and Dll1-mediated Notch pathway in Lgr5-positive intestinal stem cells regulates the mucosal injury and repair in DSS-induced colitis mice model. Wnt/β-catenin和Dll1介导的Notch通路在Lgr5阳性肠干细胞中的合作调节了DSS诱导的结肠炎小鼠模型的粘膜损伤和修复。
IF 3.8 3区 医学
Gastroenterology Report Pub Date : 2024-10-23 eCollection Date: 2024-01-01 DOI: 10.1093/gastro/goae090
Weijun Ou, Weimin Xu, Yaosheng Wang, Zhebin Hua, Wenjun Ding, Long Cui, Peng Du
{"title":"Cooperation of Wnt/β-catenin and Dll1-mediated Notch pathway in Lgr5-positive intestinal stem cells regulates the mucosal injury and repair in DSS-induced colitis mice model.","authors":"Weijun Ou, Weimin Xu, Yaosheng Wang, Zhebin Hua, Wenjun Ding, Long Cui, Peng Du","doi":"10.1093/gastro/goae090","DOIUrl":"https://doi.org/10.1093/gastro/goae090","url":null,"abstract":"<p><strong>Background: </strong>Lgr5-positive cells located in the basal layer of crypts have self-regenerative and proliferative differentiation potentials of intestinal stem cells (ISCs), maintaining a balance of regeneration-repair in mucosal epithelium. However, the mechanisms of mucosal repair that are regulated by ISCs in ulcerative colitis (UC) remain unclear.</p><p><strong>Method: </strong>Colon tissues from patients with UC were collected to test β-catenin and Notch1 expression by using Western blot and quantitative real-time polymerase chain reaction (PCR). <i>β-catenin<sup>fl/fl</sup></i> mice, <i>β-catenin<sup>Tg</sup></i> mice, and <i>Dll1<sup>tm1 Gos</sup></i> mice were used to cross with <i>Lgr5-EGFP-IRES-creERT2</i> mice to generate mice of different genotypes, altering the activation of Wnt/β-catenin and Dll1-mediated Notch signaling in ISCs <i>in vivo</i>. Dextran sulfate sodium (DSS) was used to induce a colitis mice model. Intestinal organoids were isolated and cultured to observe the proliferation and differentiation levels of ISCs.</p><p><strong>Result: </strong>β-catenin and Notch1 expression were significantly increased in the inflamed colon tissues from patients with UC. Wnt/β-catenin activation and Dll1-mediated Notch pathway inhibition in Lgr5-positive stem cells promoted the expressions of E-cadherin, CK20, and CHGA in colonic organoids and epithelium, implying the promotion of colonic epithelial integrity. Activation of Wnt/β-catenin and suppression of Dll1-mediated Notch pathway in Lgr5-positive ISCs alleviated the DSS-induced intestinal mucosal inflammation in mice.</p><p><strong>Conclusions: </strong>Lgr5-positive ISCs are characterized by self-renewal and high dividend potential, which play an important role in the injury and repair of intestinal mucosa. More importantly, the Wnt/β-catenin signaling pathway cooperates with the Notch signaling pathway to maintain the function of the Lgr5-positive ISCs.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11498905/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postpartum hepatitis flares in mothers with chronic hepatitis B infection. 慢性乙型肝炎感染母亲产后肝炎复发。
IF 3.8 3区 医学
Gastroenterology Report Pub Date : 2024-10-22 eCollection Date: 2024-01-01 DOI: 10.1093/gastro/goae091
Shi OuYang, Yawen Geng, Gongqin Qiu, Yueying Deng, Haitao Deng, Calvin Q Pan
{"title":"Postpartum hepatitis flares in mothers with chronic hepatitis B infection.","authors":"Shi OuYang, Yawen Geng, Gongqin Qiu, Yueying Deng, Haitao Deng, Calvin Q Pan","doi":"10.1093/gastro/goae091","DOIUrl":"https://doi.org/10.1093/gastro/goae091","url":null,"abstract":"<p><p>Postpartum elevation of alanine aminotransferase (ALT) in mothers with chronic hepatitis B (CHB) presents a significant clinical challenge. However, the existing literature demonstrates inconsistencies regarding its incidence and predictors in mothers infected with the hepatitis B virus (HBV). Recent advancements in antiviral prophylaxis against mother-to-child transmission of HBV and postpartum cessation of antiviral therapy further complicate this issue. Our literature review, spanning PubMed, and two Chinese-language databases (CNKI and Wanfang) from 1 January 2000 to 31 December 2023 aimed to consolidate and analyse available data on the frequency and severity of postpartum ALT flares, identify risk factors, and propose a management algorithm. Data from 23 eligible studies involving 8,077 pregnant women revealed an overall incidence of postpartum ALT elevation: 25.7% for mild cases, 4.4% for moderate cases, and 1.7% for severe cases. In the subgroup of mothers who were HBeAg-positive and on antiviral prophylaxis for preventing mother-to-child transmission, postpartum intermediate and severe ALT elevations were reported with pooled rates of 5.9% and 0.8%, respectively. Importantly, none resulted in mortality or necessitated liver transplantation. Identified risk factors for postpartum ALT flares in mothers with CHB included HBV DNA levels, ALT levels during pregnancy, postpartum cessation of antiviral treatment, and HBeAg status. By leveraging this evidence and recent data on predictors of intermediate or severe postpartum ALT flares, we propose a risk-stratified algorithm for managing postpartum ALT elevation and selecting therapy in mothers with CHB, tailoring different approaches for treatment-naive vs treatment-experienced populations. These recommendations aim to provide guidance for clinical decision-making and enhance patient outcomes.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495872/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HCV elimination: is the bulk of the iceberg being missed? 消除 HCV:冰山一角是否被遗漏?
IF 3.8 3区 医学
Gastroenterology Report Pub Date : 2024-10-15 eCollection Date: 2024-01-01 DOI: 10.1093/gastro/goae093
Eric Kalo, Asma Baig, Alison Derrett, Scott Read, Golo Ahlenstiel
{"title":"HCV elimination: is the bulk of the iceberg being missed?","authors":"Eric Kalo, Asma Baig, Alison Derrett, Scott Read, Golo Ahlenstiel","doi":"10.1093/gastro/goae093","DOIUrl":"https://doi.org/10.1093/gastro/goae093","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11479704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Active role of the immune system in metabolic dysfunction-associated steatotic liver disease. 免疫系统在代谢功能障碍相关性脂肪肝中的积极作用。
IF 3.8 3区 医学
Gastroenterology Report Pub Date : 2024-10-15 eCollection Date: 2024-01-01 DOI: 10.1093/gastro/goae089
Taizo Mori, Sachiyo Yoshio, Eiji Kakazu, Tatsuya Kanto
{"title":"Active role of the immune system in metabolic dysfunction-associated steatotic liver disease.","authors":"Taizo Mori, Sachiyo Yoshio, Eiji Kakazu, Tatsuya Kanto","doi":"10.1093/gastro/goae089","DOIUrl":"https://doi.org/10.1093/gastro/goae089","url":null,"abstract":"<p><p>Non-alcoholic fatty liver disease, recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD), is a complex multifactorial disease that progresses from steatohepatitis (MASH) to liver cirrhosis and liver cancer. Recent research has revealed that crosstalk between innate immune cells and hepatic parenchymal and non-parenchymal cells is involved in the pathogenesis of liver disease in MASLD/MASH. Of particular importance, novel inflammatory mechanisms, including macrophage diversity, neutrophil NETosis, B-cell biology, auto-reactive T cells, unconventional T cells, and dendritic cell-T cell interactions, are considered key drivers for disease progression. These mechanisms and factors are potential targets for the therapeutic intervention of MASLD/MASH. In this review, we focus on recent discoveries related to liver inflammation and discuss the role of innate immune cell subsets in MASLD/MASH.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11479709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases? 更正:2024 年肝纤维化无创检测:不同疾病是否有不同量表?
IF 3.8 3区 医学
Gastroenterology Report Pub Date : 2024-10-12 eCollection Date: 2024-01-01 DOI: 10.1093/gastro/goae096
{"title":"Correction to: Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases?","authors":"","doi":"10.1093/gastro/goae096","DOIUrl":"https://doi.org/10.1093/gastro/goae096","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1093/gastro/goae024.].</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11481166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A predictive model and rapid multi-dynamic algorithm developed based on tumor-stroma percentage in gastric cancer: a retrospective, observational study. 基于胃癌肿瘤间质百分比开发的预测模型和快速多动态算法:一项回顾性观察研究。
IF 3.8 3区 医学
Gastroenterology Report Pub Date : 2024-10-11 eCollection Date: 2024-01-01 DOI: 10.1093/gastro/goae083
Yitian Xu, Yan Yang, Feichi Cheng, Zai Luo, Yuan Zhang, Pengshan Zhang, Jiahui Qiu, Zhengjun Qiu, Chen Huang
{"title":"A predictive model and rapid multi-dynamic algorithm developed based on tumor-stroma percentage in gastric cancer: a retrospective, observational study.","authors":"Yitian Xu, Yan Yang, Feichi Cheng, Zai Luo, Yuan Zhang, Pengshan Zhang, Jiahui Qiu, Zhengjun Qiu, Chen Huang","doi":"10.1093/gastro/goae083","DOIUrl":"https://doi.org/10.1093/gastro/goae083","url":null,"abstract":"<p><strong>Background: </strong>Tumor-stroma percentage (TSP) is a prognostic risk factor in numerous solid tumors. Despite this, the prognostic significance of TSP in gastric cancer (GC) remains underexplored. Through the development of a personalized predictive model and a semi-automatic identification system, our study aimed to fully unlock the predictive potential of TSP in GC.</p><p><strong>Methods: </strong>We screened GC patients from Shanghai General Hospital (SGH) between 2012 and 2019 to develop and validate a nomogram. Univariate and multivariate Cox proportional hazards regression analyses were employed to identify independent prognostic factors influencing the prognosis for GC patients. The nomogram was further validated externally by using a cohort from Bengbu Medical College (BMC). All patients underwent radical gastrectomy, with those diagnosed with locally advanced GC receiving adjuvant chemotherapy. The primary outcome measured was overall survival (OS). The semi-automatic identification of the TSP was achieved through a computer-aided detection (CAD) system, denoted as TSP-cad, while TSP identified by pathologists was labeled as TSP-visual.</p><p><strong>Results: </strong>A total of 813 GC patients from SGH and 59 from BMC were enrolled in our study. TSP-visual was identified as an adverse prognostic factor for OS in GC and was found to be associated with pathological Tumor Node Metastasis staging system (pTNM) stage, T stage, N stage, perineural invasion (PNI), lymphovascular invasion (LVI), TSP-visual, tumor size, and other factors. Multivariate Cox regression using the training cohort revealed that TSP-visual (hazard ratio [HR], 2.042; 95% confidential interval [CI], 1.485-2.806; <i>P </i><<i> </i>0.001), N stage (HR, 2.136; 95% CI, 1.343-3.397; <i>P </i>=<i> </i>0.010), PNI (HR , 1.791; 95% CI, 1.270-2.526; <i>P </i>=<i> </i>0.001), and LVI (HR, 1.482; 95% CI, 1.021-2.152; <i>P </i>=<i> </i>0.039) were independent predictors. These factors were incorporated into a novel nomogram, which exhibited strong predictive accuracy for 5-year OS in the training, internal validation, and external validation cohorts (area under the curve = 0.744, 0.759, and 0.854, respectively). The decision curve analysis of the nomogram and concordance indexes across the three cohorts outperformed the traditional pTNM (<i>P </i><<i> </i>0.05). Additionally, TSP-cad assessment using a rapid multi-dynamic algorithm demonstrated good agreement with TSP-visual.</p><p><strong>Conclusions: </strong>The novel nomogram based on TSP could effectively identify individuals at risk of a poor prognosis among patients with GC. TSP-cad is anticipated to enhance the evaluation process of TSP.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11470210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of actionable gene fusions in a large cohort of Chinese patients with colorectal cancer. 大样本中国结直肠癌患者可操作基因融合分析。
IF 3.8 3区 医学
Gastroenterology Report Pub Date : 2024-10-09 eCollection Date: 2024-01-01 DOI: 10.1093/gastro/goae092
Fu-Rong Kou, Jian Li, Zheng-Hang Wang, Ting Xu, Juan-Juan Qian, En-Li Zhang, Li-Jun Zhang, Lin Shen, Xi-Cheng Wang
{"title":"Analysis of actionable gene fusions in a large cohort of Chinese patients with colorectal cancer.","authors":"Fu-Rong Kou, Jian Li, Zheng-Hang Wang, Ting Xu, Juan-Juan Qian, En-Li Zhang, Li-Jun Zhang, Lin Shen, Xi-Cheng Wang","doi":"10.1093/gastro/goae092","DOIUrl":"10.1093/gastro/goae092","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of gene fusion is extremely low in unselected patients with colorectal cancer (CRC). Published data on gene fusions are limited by relatively small sample sizes, with a primary focus on Western populations. This study aimed to analyse actionable gene fusions in a large consecutive Chinese CRC population.</p><p><strong>Methods: </strong>This study included 5,534 consecutive CRC patients from the Genecast database. Genomic profiling was performed using a panel of 769 cancer-related genes. Data for 34 CRC patients with actionable gene fusions were also collected from cBioPortal and ChimerSeq.</p><p><strong>Results: </strong>Among 5,534 CRC patients, 54 (0.98%) had actionable gene fusions, with <i>NTRK1/2/3</i> being the most common fusion (0.38%), accounting for 38.9% (21/54) of those with fusions. Actionable gene fusion enrichment was higher in patients with microsatellite instability-high (MSI-H) (6.7% vs. 0.5%, <i>P </i><<i> </i>0.001), <i>RAS/BRAF</i> wildtype (2.0% vs. 0.2%, <i>P </i><<i> </i>0.001) and <i>RNF43</i> mutation (7.7% vs. 0.4%, <i>P </i><<i> </i>0.001) than in patients with microsatellite stability/MSI-low, <i>RAS/BRAF</i> mutation and <i>RNF43</i> wildtype, respectively. When these markers were combined, the fusion detection rate increased. Among patients with <i>RAS/BRAF</i> wildtype and MSI-H, fusions were detected in 20.3% of patients. The fusion detection rate further increased to 37.5% when <i>RNF43</i> mutation was added. The fusion detection rate was also higher in colon cancer than in rectal cancer. No significant differences in clinical or molecular features were found in patients with actionable gene fusions between the Genecast, cBioPortal, and ChimerSeq databases.</p><p><strong>Conclusions: </strong>Approximately 1% of the unselected Chinese CRC population carries actionable gene fusions, mostly involving <i>NTRK</i>. Actionable gene fusions are more prevalent in MSI-H, <i>RAS/BRAF</i> wildtype, or <i>RNF43</i>-mutated CRC, as well as in colon cancer. Mapping of these molecular markers can markedly increase the fusion detection rate, which can help clinicians select candidates for fusion testing and targeted therapy.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11464618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信